AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors at its meeting held has decided to transfer Rs 100 million to General Reserve and recommended declaration of dividend @ 35% subject to the approval of the Shareholders at the Annual General Meeting.
Further, the Board accepted the resignation of R M Henry, Director, effective from the close of January 31, 2003.